American Association of Clinical Urologists, Inc.

In this K-Cast video series, Neal Shore, MD, describes current standards in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and provides an overview of data from the PROfound ...

“Nivolumab, combined with standard of care trimodality therapy, appears to be promising for the treatment of grade group 5 prostate cancer," says John Michael Bryant, MD.

"This study is significant because it really emphasizes the importance of early detection of both BPH and ED, because knowing that information can really preserve men's quality of life," says Olivia ...

CREST, POTOMAC, KEYNOTE, and ALBAN trials investigate PD-1/PD-L1 inhibitors for BCG-naive bladder cancer patients, focusing on efficacy and safety. Routes of administration vary, with some trials ...

Female bladder cancer patients undergoing bladder-sparing therapies often experience minimal disruption to sexual health compared to those undergoing cystectomy. The study underscores the need for ...

Bel-sar is a virus drug conjugate using HPV virus-like particles conjugated to a cytotoxic drug for targeted cancer cell destruction. The therapy targets heparan sulfate proteoglycans on cancer cells, ...

In this video, Bridget F. Koontz, MD, FASTRO, highlights the role that PSMA-PET imaging has played in enabling more targeted treatment for prostate cancer. Koontz is radiation oncologist and the ...

LiSWT and PRP independently and combined significantly improved IIEF scores in ED treatment compared to control therapy. LiSWT was the most effective standalone treatment, with a mean IIEF score ...

The panelist discusses how 68gallium prostate-specific membrane antigen-11 (PSMA-11) gozetotide is most useful in PET-CT imaging for detecting and staging prostate cancer.

Regular physical activity, following American guidelines, improves sexual quality of life for both males and females. A plant-based diet is associated with a lower risk of erectile dysfunction, even ...

"The biomarker is better at predicting presence of disease than absence, and the reason that that's important is that's how we can think about the biomarker aiding in careful clinical assessment of ...